Effects of morning or bedtime dosing of the valsartan/amlodipine on nocturnal blood pressure and target organ protection in patients with hypertension

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 06 Jun 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

30 May 2018 Results of a sub-analysis assessing the association of changes in Brachial/central nocturnal SBP with change in urine albumin-creatinine ratio, published in the American Journal of Hypertension
26 Oct 2015 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
29 Sep 2015 Planned End Date changed from 30 Sep 2015 to 14 Aug 2015, as reported by University Hospital Medical Information Network - Japan record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com